Follicular lymphoma: treatment guidance in times of change

C Buske¹

Affiliations

¹ Department of Internal Medicine III, Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de.

Free article

Editorial

C Buske. Ann Oncol. 2021 Mar.

Free article

. 2021 Mar;32(3):293-294.

doi: 10.1016/j.annonc.2021.01.001. Epub 2021 Jan 9.

C Buske¹

¹ Department of Internal Medicine III, Comprehensive Cancer Center Ulm, Institute of Experimental Cancer Research, University Hospital, Ulm, Germany. Electronic address: christian.buske@uni-ulm.de.

No abstract available

Conflict of interest statement

Disclosure Research funding: CB: Janssen, Roche, Bayer. Honorarium: Janssen, Roche, Bayer, Abbvie, BMS, Gilead, Pfizer, Celltrion.

Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Dreyling M, Ghielmini M, Rule S, Salles G, Ladetto M, Tonino SH, Herfarth K, Seymour JF, Jerkeman M; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Dreyling M, et al. Ann Oncol. 2021 Mar;32(3):298-308. doi: 10.1016/j.annonc.2020.11.008. Epub 2020 Nov 26. Ann Oncol. 2021. PMID: 33249059 No abstract available.